ROLE AND REGULATION OF CDK4 IN THE NORMAL LENS
ROLE AND REGULATION OF CDK4 IN THE NORMAL LENS
批准号:
6138198
负责人:
RONALD ANTHONY DEPINHO
金额:
$33.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-01-26 至 2000-12-31
关键词:
cell cycle cell differentiation cell growth regulation cyclin dependent kinase cyclins developmental genetics enzyme activity gene expression gene mutation genetically modified animals growth factor immunocytochemistry in situ hybridization laboratory mouse laboratory rat lens neoplastic transformation phenotype phosphorylation protein structure function protooncogene retinoblastoma protein tumor suppressor genes western blottings
中文摘要
阐明了控制细胞生长的分子机制,
对我们理解正常发育和癌症至关重要。的目标
本研究的目的是探索细胞周期的主要调控机制,
检查点,G1/S转换,在发育小鼠的背景下
透镜。我们的主要重点将是对G1细胞周期蛋白依赖的调控,
激酶(cdk),cdk 4及其与视网膜母细胞瘤的功能关系
(Rb)蛋白cdk 4复合体已经占据了细胞周期的中心阶段
由于其在增殖反应中的重要性,
细胞对生长因子及其相关蛋白质的参与
在癌症发病机制中。cdk 4复合物的活性在很大程度上受到调节。
通过与阳性(细胞周期蛋白D)和阴性(细胞周期蛋白D)的直接相互作用
(cdk 4的抑制剂,例如p15/INK 4和p16 INK 4)调节蛋白。由于
在过去6年的基础上,我的实验室现在是独一无二的。
能够以全面的方式处理cdk 4的功能,
其相关的调节蛋白在正常哺乳动物发育中的作用。这
机会来自于(i)将透镜建立为理想系统
用于检查体内生长控制(EMBO J,1995),并证明
Rb是cdk 4的底物,在透镜细胞中起着核心和重要的作用
生长控制(自然,1994年),(ii)功能的表征
几种细胞中p16 INK 4、cdk 4、Myc和Rb蛋白相互关系
培养系统(Science,1995),(iii)产生4种不同的转基因
小鼠系(各种细胞周期蛋白D和cdk 4构建体)和种系空
p16 INK 4基因的突变,(iv)癌症易感转基因的可用性,
我们和其他人已经生成的小鼠模型,最重要的是,(v)
在使用小鼠作为实验系统方面的丰富经验,
基因功能分析。这一完整补充的特征
功能获得和功能丧失小鼠模型将使我们能够
了解细胞周期蛋白D、cdk 4和p15 INK 4、p16 INK 4基因在
在体内正常组织中和在体内正常组织中G1/S转换的调节,
癌症的起源关于癌症研究,我们将检查和
比较每种小鼠模型中肿瘤的发生和分布
单独地,彼此结合,或与癌症结合-
易感小鼠(如p53-/-或我们的一些Myc转基因小鼠)。最后
p16 INK 4与家族性黑色素瘤的联系将促使对
无p16 INK小鼠的UV暴露是否加速皮肤的发育
癌的
英文摘要
Elucidation of the molecular mechanisms governing cellular growth is
central to our understanding of normal development and cancer. The goal of
this proposal is to explore the regulation of the principal cell cycle
checkpoint, the G1/S transition, in the context of the developing mouse
lens. Our main focus will be on the regulation of a G1 cyclin-dependent
kinase (cdk), cdk4, and its functional relationship to the retinoblastoma
(Rb) protein. The cdk4 complex has captured center stage in the cell cycle
field because of its documented importance in the proliferative response of
cells to growth factors and of the involvement of its associated proteins
in cancer pathogenesis. Activity of the cdk4 complex is regulated in large
part through direct interactions with positive (cyclin D) and negative
(inhibitors of cdk4, e.g. p15/INK4 and p16INK4) modulatory proteins. Owing
to a foundation laid over the past 6 years, my laboratory is now uniquely
positioned to address in a comprehensive manner the function of cdk4 and
its associated regulatory proteins in normal mammalian development. This
opportunity arises from (i) establishment of the lens as an ideal system
for examining growth control in vivo (EMBO J, 1995) and demonstration that
Rb, the substrate of cdk4, plays a central and essential role in lens cell
growth control (Nature, 1994), (ii) characterization of the functional
interrelationships among p16INK4, cdk4, Myc and Rb proteins in several cell
culture systems (Science, 1995), (iii) generation of 4 different transgenic
mouse lines (various cyclin D and cdk4 constructs) and a germline null
mutation of the pl6INK4 gene, (iv) availability of cancer-prone transgenic
mouse models that we and others have generated, and most importantly, (v)
extensive experience in employing the mouse as an experimental system for
the analysis of gene function. Characterization of this full complement of
gain-of function and loss-of-function mouse models will allow us to
understand the function of cyclin D, cdk4, and p15INK4, p16INK4 genes in
the regulation of the G1/S transition in normal tissues in vivo and in the
genesis of cancer. With respect to the cancer studies, we will examine and
compare the onset and distribution of tumors arising in each mouse model
separately, in combination with each other, or in conjunction with cancer-
prone mice (such as p53-/- or some of our Myc transgenics). Finally, the
connection of p16INK4 to familial melanoma will prompt an assessment of
whether UV exposure of null p16INK mice accelerates the development of skin
cancers.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1101/gad.12.20.3162
发表时间:
1998-10
期刊:
Genes & development
影响因子:
10.5
作者:
[Pumin Zhang;C. Wong;R. DePinho;J. Harper;S. Elledge]
通讯作者:
Pumin Zhang;C. Wong;R. DePinho;J. Harper;S. Elledge
Identifying and targeting collateral lethal vulnerabilities in cancers
-
批准号:10563469
-
项目类别:
-
资助金额:$96.7万
-
财政年份:2023
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Exploring Collateral Lethality for Development of Cancer Therapeutics
-
批准号:10365970
-
项目类别:
-
资助金额:$46.43万
-
财政年份:2018
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Genetics and Biology of Metastatic Colorectal Cancer
-
批准号:9768989
-
项目类别:
-
资助金额:$35.38万
-
财政年份:2018
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Exploring Collateral Lethality for Development of Cancer Therapeutics
-
批准号:9899100
-
项目类别:
-
资助金额:$47.41万
-
财政年份:2018
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Genetics and Biology of Metastatic Colorectal Cancer
-
批准号:10229510
-
项目类别:
-
资助金额:$36.48万
-
财政年份:2018
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Genetics and Biology of Metastatic Colorectal Cancer
-
批准号:10474624
-
项目类别:
-
资助金额:$38.18万
-
财政年份:2018
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Cancer Clinical Investigator Team Leadership Award
-
批准号:8759976
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2013
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Cancer Center Support Grant - CTRP Supplement
-
批准号:8759942
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2013
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Program Leaders of Research Programs
-
批准号:8759762
-
项目类别:
-
资助金额:$57.04万
-
财政年份:2013
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Genetic Engineering Mouse Core
-
批准号:8052127
-
项目类别:
-
资助金额:$8.38万
-
财政年份:2011
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
FUNCTIONAL GENOMIC IDENTIFICATION AND CHARACTERIZATION OF THERAPEUTIC TARGETS
-
批准号:8052103
-
项目类别:
-
资助金额:$31.95万
-
财政年份:2011
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
ADMINISTRATION CORE
-
批准号:8052128
-
项目类别:
-
资助金额:$3.43万
-
财政年份:2011
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
The role of FOXO transcriptional factors in TSC-mediated tumorigenesis
-
批准号:7679614
-
项目类别:
-
资助金额:$20.52万
-
财政年份:2008
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
The role of FOXO transcriptional factors in TSC-mediated tumorigenesis
-
批准号:7511002
-
项目类别:
-
资助金额:$17.1万
-
财政年份:2008
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Project 1: Targeting Metabolic Dependencies in PDAC
-
批准号:9074440
-
项目类别:
-
资助金额:$57.52万
-
财政年份:2006
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
-
批准号:8603762
-
项目类别:
-
资助金额:$205.71万
-
财政年份:2006
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Genetics and Biology of Pancreatic Duct Adenocarcinoma
-
批准号:7591831
-
项目类别:
-
资助金额:$183.84万
-
财政年份:2006
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
-
批准号:8019210
-
项目类别:
-
资助金额:$201.96万
-
财政年份:2006
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Genetics and Biology of Pancreatic Duct Adenocarcinoma
-
批准号:7928430
-
项目类别:
-
资助金额:$48.8万
-
财政年份:2006
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Genetics and Biology of Pancreatic Duct Adenocarcinoma
-
批准号:7223402
-
项目类别:
-
资助金额:$177.09万
-
财政年份:2006
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
海外基金